Welcome to LookChem.com Sign In|Join Free

CAS

  • or

126-19-2

Post Buying Request

126-19-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

126-19-2 Usage

Description

Smilagengenin is a steroidal saponin with antitumor activity, which is mainly used in refreshing beverages, foaming sweets, mixed wine, etc.

Uses

Sarsasapogenin has cytotoxic properties and is used to develop lead structures for cancer drugs. Sarsasapogenin is also identified to effectively lower the production of Aβ amyloids and stimulate neurite ogrowth in neuronal cell cultures.

Check Digit Verification of cas no

The CAS Registry Mumber 126-19-2 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 1,2 and 6 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 126-19:
(5*1)+(4*2)+(3*6)+(2*1)+(1*9)=42
42 % 10 = 2
So 126-19-2 is a valid CAS Registry Number.
InChI:InChI=1/C27H44O3/c1-16-7-12-27(29-15-16)17(2)24-23(30-27)14-22-20-6-5-18-13-19(28)8-10-25(18,3)21(20)9-11-26(22,24)4/h16-24,28H,5-15H2,1-4H3/t16-,17+,18-,19-,20+,21+,22+,23-,24-,25-,26-,27-/m0/s1

126-19-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name (25S)-5β-spirostan-3β-ol

1.2 Other means of identification

Product number -
Other names Spirostan-3-ol, (3β,5β,25S)-

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:126-19-2 SDS

126-19-2Synthetic route

pseudosarsasapogenin
18831-15-7

pseudosarsasapogenin

sarsasapogenin
126-19-2

sarsasapogenin

Conditions
ConditionsYield
With hydrogenchloride In methanol at 20℃; for 12h; Cycloaddition;100%
anemarrhenasaponin IV
142759-74-8

anemarrhenasaponin IV

A

sarsasapogenin-3-O-β-galactopyranoside
68422-00-4

sarsasapogenin-3-O-β-galactopyranoside

B

timosaponin B III-b
1365029-75-9

timosaponin B III-b

C

3β-hydroxy-5β-pregn-16(17)-ene-20-one
566-59-6

3β-hydroxy-5β-pregn-16(17)-ene-20-one

D

timopregnane A

timopregnane A

E

3-O-β-D-galactopyranosyl-(3β,5β)-pregn-16(17)-ene-20-one

3-O-β-D-galactopyranosyl-(3β,5β)-pregn-16(17)-ene-20-one

F

timosaponin B III-d

timosaponin B III-d

G

(25S)-5β-spirostan-3β-ol-3-O-β-D-glucopyranosyl-(1->2)-β-D-galactopyranoside

(25S)-5β-spirostan-3β-ol-3-O-β-D-glucopyranosyl-(1->2)-β-D-galactopyranoside

H

sarsasapogenin
126-19-2

sarsasapogenin

Conditions
ConditionsYield
With nitric acid In water at 100℃; for 3h;A 15 mg
B 25 mg
C 30 mg
D 20 mg
E 10 mg
F 18 mg
G 13 mg
H 42 mg
3-O-<<α-L-rhamnopyranosyl(1->4)><β-D-glucopyranosyl(1->2)>-β-D-glucopyranosyl>-(25S)-5β-spirostan-3β-ol

3-O-<<α-L-rhamnopyranosyl(1->4)><β-D-glucopyranosyl(1->2)>-β-D-glucopyranosyl>-(25S)-5β-spirostan-3β-ol

sarsasapogenin
126-19-2

sarsasapogenin

Conditions
ConditionsYield
With hydrogenchloride In methanol at 100℃;
Multi-step reaction with 2 steps
1: 1M HCl / butan-1-ol / 1 h / 70 °C
2: 2M HCl / methanol / 100 °C
View Scheme
Multi-step reaction with 2 steps
1: 1M HCl / butan-1-ol / 1 h / 70 °C
2: 2M HCl / methanol / 100 °C
View Scheme
Multi-step reaction with 2 steps
1: 5percent aq. HCl / methanol / 0.75 h / Heating
2: 7percent H2SO4 / 4 h / Heating
View Scheme
26-O-β-D-glucopyransoyl-(25S)-5β-furostane-3β,22ξ,26-triol 3-O-[β-D-xylopyranosyl (1->6)]-β-D-glucopyranside

26-O-β-D-glucopyransoyl-(25S)-5β-furostane-3β,22ξ,26-triol 3-O-[β-D-xylopyranosyl (1->6)]-β-D-glucopyranside

sarsasapogenin
126-19-2

sarsasapogenin

Conditions
ConditionsYield
With hydrogenchloride In 1,4-dioxane for 3h; Heating;70.4%
pseudosarsasapogenin
18831-15-7

pseudosarsasapogenin

A

C27H44O3

C27H44O3

B

C27H44O3

C27H44O3

C

sarsasapogenin
126-19-2

sarsasapogenin

Conditions
ConditionsYield
With acetic acid at 20℃; for 12h; Cycloaddition;A 13.2%
B 57.4%
C 2.7%
(25S)-5β-spirostan-3β-yl-[α-L-rhamnopyranosyl-(1->4)]-β-D-glucopyranoside
58881-26-8

(25S)-5β-spirostan-3β-yl-[α-L-rhamnopyranosyl-(1->4)]-β-D-glucopyranoside

sarsasapogenin
126-19-2

sarsasapogenin

Conditions
ConditionsYield
With hydrogenchloride In methanol at 100℃;
(25S)-5β-spirostan-3β-ol 3-O-β-D-glucopyranosyl-(1->2)-β-D-glucopyranoside
84633-33-0

(25S)-5β-spirostan-3β-ol 3-O-β-D-glucopyranosyl-(1->2)-β-D-glucopyranoside

sarsasapogenin
126-19-2

sarsasapogenin

Conditions
ConditionsYield
With hydrogenchloride In methanol at 100℃;
Glycoside-AR-4

Glycoside-AR-4

sarsasapogenin
126-19-2

sarsasapogenin

Conditions
ConditionsYield
With sulfuric acid In 1,4-dioxane for 4h; Heating;55%
(25S)-5β-spirostan-3β-ol 3-O-{β-D-glucopyranosyl-(1->6)-[α-L-rhamnopyranosyl-(1->6)-β-D-glucopyranosyl-(1->4)]-β-D-glucopyranoside}

(25S)-5β-spirostan-3β-ol 3-O-{β-D-glucopyranosyl-(1->6)-[α-L-rhamnopyranosyl-(1->6)-β-D-glucopyranosyl-(1->4)]-β-D-glucopyranoside}

sarsasapogenin
126-19-2

sarsasapogenin

Conditions
ConditionsYield
With hydrogenchloride In 1,4-dioxane at 80℃; for 3h;
(25S)-5β-spirostan-3β-ol 3-O-[α-L-rhamnopyranosyl-(1->6)-β-D-glucopyranosyl-(1->6)-β-D-glucopyranoside]

(25S)-5β-spirostan-3β-ol 3-O-[α-L-rhamnopyranosyl-(1->6)-β-D-glucopyranosyl-(1->6)-β-D-glucopyranoside]

sarsasapogenin
126-19-2

sarsasapogenin

Conditions
ConditionsYield
With hydrogenchloride In 1,4-dioxane at 80℃; for 3h;
(25S)-5β-spirostan-3β-ol 3-O-{α-L-rhamnopyranosyl-(1->6)-[α-L-rhamnopyranosyl-(1->4)]-β-D-glucopyranoside}

(25S)-5β-spirostan-3β-ol 3-O-{α-L-rhamnopyranosyl-(1->6)-[α-L-rhamnopyranosyl-(1->4)]-β-D-glucopyranoside}

sarsasapogenin
126-19-2

sarsasapogenin

Conditions
ConditionsYield
With hydrogenchloride In 1,4-dioxane at 80℃; for 3h;
sarsasapogenin
126-19-2

sarsasapogenin

Conditions
ConditionsYield
With sulfuric acid In 1,4-dioxane for 4h; Heating;55%
Conditions
ConditionsYield
With tetrabutylammonium tetrafluoroborate In tetrahydrofuran Electrochemical reaction;A 48%
B 32%
3-O-<<α-L-rhamnopyranosyl(1->4)><β-D-glucopyranosyl(1->2)>-β-D-glucopyranosyl>-(25S)-5β-spirostan-3β-ol

3-O-<<α-L-rhamnopyranosyl(1->4)><β-D-glucopyranosyl(1->2)>-β-D-glucopyranosyl>-(25S)-5β-spirostan-3β-ol

A

(25S)-5β-spirostan-3β-yl-[α-L-rhamnopyranosyl-(1->4)]-β-D-glucopyranoside
58881-26-8

(25S)-5β-spirostan-3β-yl-[α-L-rhamnopyranosyl-(1->4)]-β-D-glucopyranoside

B

(25S)-5β-spirostan-3β-ol 3-O-β-D-glucopyranosyl-(1->2)-β-D-glucopyranoside
84633-33-0

(25S)-5β-spirostan-3β-ol 3-O-β-D-glucopyranosyl-(1->2)-β-D-glucopyranoside

C

sarsasapogenin
126-19-2

sarsasapogenin

Conditions
ConditionsYield
With hydrogenchloride In butan-1-ol at 70℃; for 1h; Yields of byproduct given;
(25S)-5β-spirostan-3β-ol 3-O-α-L-arabinopyranosyl-(1->4)-[β-D-glucopyranosyl-(1->2)]-β-D-glucopyranoside
84765-74-2

(25S)-5β-spirostan-3β-ol 3-O-α-L-arabinopyranosyl-(1->4)-[β-D-glucopyranosyl-(1->2)]-β-D-glucopyranoside

sarsasapogenin
126-19-2

sarsasapogenin

Conditions
ConditionsYield
With sulfuric acid In water for 3h; Heating;
Multi-step reaction with 2 steps
1: 250 mg / 1percent H2SO4 / methanol / 4 h / Ambient temperature
2: 7percent H2SO4 / H2O / 3 h / Heating
View Scheme
Multi-step reaction with 2 steps
1: 250 mg / 1percent H2SO4 / methanol / 96 h / Ambient temperature
2: 7percent H2SO4 / H2O / 3 h / Heating
View Scheme
(25S)-5β-furost-20(22)-ene-3β,26-diyl diacetate
838087-02-8

(25S)-5β-furost-20(22)-ene-3β,26-diyl diacetate

A

sarsasapogenin
126-19-2

sarsasapogenin

B

CH3CO-X

CH3CO-X

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 84.1 percent / KOH / methanol / 20 °C
2: 100 percent / HCl / methanol / 12 h / 20 °C
View Scheme
Multi-step reaction with 2 steps
1: 84.1 percent / KOH / methanol / 20 °C
2: 2.7 percent / HOAc / 12 h / 20 °C
View Scheme
C44H72O16

C44H72O16

sarsasapogenin
126-19-2

sarsasapogenin

Conditions
ConditionsYield
With sulfuric acid In water for 3h; Heating;
Multi-step reaction with 2 steps
1: 200 mg / 1percent H2SO4 / methanol / 4 h / Ambient temperature
2: 7percent H2SO4 / H2O / 3 h / Heating
View Scheme
C38H62O12
346617-77-4

C38H62O12

sarsasapogenin
126-19-2

sarsasapogenin

Conditions
ConditionsYield
With sulfuric acid In water for 3h; Heating;
sarsasapogenyl β-D-glucopyranosyl-(1->4)-[α-L-arabinopyranosyl-(1->6)]-β-D-glucopyranoside

sarsasapogenyl β-D-glucopyranosyl-(1->4)-[α-L-arabinopyranosyl-(1->6)]-β-D-glucopyranoside

sarsasapogenin
126-19-2

sarsasapogenin

Conditions
ConditionsYield
With hydrogenchloride In 1,4-dioxane; water for 1.5h; Heating;3.0 mg
(25S)-5β-spirostan-3β-hydroxy-3-O-β-xylopyranosyl(1->2)-[α-rhamnopyranosyl(1->4)]-β-glucopyranoside

(25S)-5β-spirostan-3β-hydroxy-3-O-β-xylopyranosyl(1->2)-[α-rhamnopyranosyl(1->4)]-β-glucopyranoside

sarsasapogenin
126-19-2

sarsasapogenin

Conditions
ConditionsYield
In ethanol; sulfuric acid at 100℃; for 6h;3 mg
C44H72O16

C44H72O16

A

C38H62O12
346617-77-4

C38H62O12

B

C39H64O12

C39H64O12

C

sarsasapogenin
126-19-2

sarsasapogenin

D

(25S)-5β-spirostan-3β-ol 3-O-β-D-glucopyranoside
14835-43-9

(25S)-5β-spirostan-3β-ol 3-O-β-D-glucopyranoside

Conditions
ConditionsYield
With sulfuric acid In methanol for 4h; Ambient temperature;A 200 mg
B 200 mg
C 30 mg
D 150 mg
With sulfuric acid In methanol for 4h; Ambient temperature;A 200 mg
B 300 mg
C 30 mg
D 150 mg
sarsasapogenone
639-96-3

sarsasapogenone

A

3α-hydroxy sarsasapogenin
470-03-1

3α-hydroxy sarsasapogenin

B

sarsasapogenin
126-19-2

sarsasapogenin

Conditions
ConditionsYield
With lithium aluminium tetrahydride In tetrahydrofuranA 300 mg
B 50 mg
(25S)-5β-spirostan-3β-ol 3-O-α-L-arabinopyranosyl-(1->4)-[β-D-glucopyranosyl-(1->2)]-β-D-glucopyranoside
84765-74-2

(25S)-5β-spirostan-3β-ol 3-O-α-L-arabinopyranosyl-(1->4)-[β-D-glucopyranosyl-(1->2)]-β-D-glucopyranoside

A

C38H62O12
346617-77-4

C38H62O12

B

(25S)-5β-spirostan-3β-ol 3-O-β-D-glucopyranosyl-(1->2)-β-D-glucopyranoside
84633-33-0

(25S)-5β-spirostan-3β-ol 3-O-β-D-glucopyranosyl-(1->2)-β-D-glucopyranoside

C

sarsasapogenin
126-19-2

sarsasapogenin

D

(25S)-5β-spirostan-3β-ol 3-O-β-D-glucopyranoside
14835-43-9

(25S)-5β-spirostan-3β-ol 3-O-β-D-glucopyranoside

Conditions
ConditionsYield
With sulfuric acid In methanol for 4h; Ambient temperature;A 250 mg
B 300 mg
C 50 mg
D 200 mg
3-O-<<α-L-rhamnopyranosyl(1->4)><β-D-glucopyranosyl(1->2)>-β-D-glucopyranosyl>-(25S)-5β-spirostan-3β-ol

3-O-<<α-L-rhamnopyranosyl(1->4)><β-D-glucopyranosyl(1->2)>-β-D-glucopyranosyl>-(25S)-5β-spirostan-3β-ol

A

(25S)-5β-spirostan-3β-yl-[α-L-rhamnopyranosyl-(1->4)]-β-D-glucopyranoside
58881-26-8

(25S)-5β-spirostan-3β-yl-[α-L-rhamnopyranosyl-(1->4)]-β-D-glucopyranoside

B

(25S)-5β-spirostan-3β-ol 3-O-β-D-glucopyranosyl-(1->2)-β-D-glucopyranoside
84633-33-0

(25S)-5β-spirostan-3β-ol 3-O-β-D-glucopyranosyl-(1->2)-β-D-glucopyranoside

C

sarsasapogenin
126-19-2

sarsasapogenin

D

(25S)-5β-spirostan-3β-ol 3-O-β-D-glucopyranoside
14835-43-9

(25S)-5β-spirostan-3β-ol 3-O-β-D-glucopyranoside

Conditions
ConditionsYield
With hydrogenchloride In methanol for 0.75h; Heating;
(25R,S)-5b-spirostan-3β-ol 3-O-

(25R,S)-5b-spirostan-3β-ol 3-O-

A

smilagenin
126-18-1

smilagenin

B

sarsasapogenin
126-19-2

sarsasapogenin

Conditions
ConditionsYield
With hydrogenchloride In 1,4-dioxane for 2h; Heating; Title compound not separated from byproducts;
(25R)-5β-spirostan-3β-ol 3-O-

(25R)-5β-spirostan-3β-ol 3-O-

A

smilagenin
126-18-1

smilagenin

B

sarsasapogenin
126-19-2

sarsasapogenin

Conditions
ConditionsYield
With hydrogenchloride In 1,4-dioxane for 2h; Heating; Title compound not separated from byproducts;
3-O-{[α-L-arabinopyranosyl-(1->2)]-[α-L-rhamnopyranosyl-(1->6)-β-D-glucopyranosyl]}-(25S)-5β-spirostan-3β-ol

3-O-{[α-L-arabinopyranosyl-(1->2)]-[α-L-rhamnopyranosyl-(1->6)-β-D-glucopyranosyl]}-(25S)-5β-spirostan-3β-ol

sarsasapogenin
126-19-2

sarsasapogenin

Conditions
ConditionsYield
With hydrogenchloride; water In 1,4-dioxane for 2h; Reflux;5.7 mg
3-O-{[β-D-glucopyranosyl-(1->2)]-[β-D-xylopyranosyl]-[α-L-rhamnopyranosyl-(1->6)-β-D-glucopyranosyl]}-(25S)-5β-spirostan-3β-ol

3-O-{[β-D-glucopyranosyl-(1->2)]-[β-D-xylopyranosyl]-[α-L-rhamnopyranosyl-(1->6)-β-D-glucopyranosyl]}-(25S)-5β-spirostan-3β-ol

sarsasapogenin
126-19-2

sarsasapogenin

Conditions
ConditionsYield
With hydrogenchloride; water In 1,4-dioxane for 2h; Reflux;4.9 mg
Conditions
ConditionsYield
With ethanol; hydrazine hydrate; ethylene glycol in wss. Alkalilauge;
parillin

parillin

sarsasapogenin
126-19-2

sarsasapogenin

Conditions
ConditionsYield
With sulfuric acid; water
tert-butyldimethylsilyl chloride
18162-48-6

tert-butyldimethylsilyl chloride

sarsasapogenin
126-19-2

sarsasapogenin

C33H58O3Si

C33H58O3Si

Conditions
ConditionsYield
In N,N-dimethyl-formamide at 70 - 90℃; for 8h;97%
tert-butyldimethylsilyl chloride
18162-48-6

tert-butyldimethylsilyl chloride

sarsasapogenin
126-19-2

sarsasapogenin

3-O-tert-butyldimethylsilyl ether of sarsasapogenin
1186633-19-1

3-O-tert-butyldimethylsilyl ether of sarsasapogenin

Conditions
ConditionsYield
With 1H-imidazole In N,N-dimethyl-formamide at 80℃; for 8h;97%
4-Nitrophenyl chloroformate
7693-46-1

4-Nitrophenyl chloroformate

sarsasapogenin
126-19-2

sarsasapogenin

C34H47NO7

C34H47NO7

Conditions
ConditionsYield
With pyridine In dichloromethane at 0 - 20℃; for 4h;95%
With pyridine In dichloromethane at 0 - 20℃; for 4h; Inert atmosphere;95%
With pyridine In dichloromethane at 20℃; for 4h; Inert atmosphere; Cooling with ice;95%
With pyridine In dichloromethane at 20℃; for 4h; Inert atmosphere;
2,3,4-tri-O-acetyl-α-L-arabinopyranosyl-(1->4)-[2,3,4-tri-O-acetyl-α-L-arabinopyranosyl-(1->6)]-2,3-di-O-acetyl-β-D-glucopyranosyl trichloroacetimidate
1344089-22-0

2,3,4-tri-O-acetyl-α-L-arabinopyranosyl-(1->4)-[2,3,4-tri-O-acetyl-α-L-arabinopyranosyl-(1->6)]-2,3-di-O-acetyl-β-D-glucopyranosyl trichloroacetimidate

sarsasapogenin
126-19-2

sarsasapogenin

(25S)-5β-spirostan-3β-ol 3-O-α-L-arabinopyranosyl-(1->6)-[α-L-arabinopyranosyl-(1->4)]-β-D-glucopyranoside

(25S)-5β-spirostan-3β-ol 3-O-α-L-arabinopyranosyl-(1->6)-[α-L-arabinopyranosyl-(1->4)]-β-D-glucopyranoside

Conditions
ConditionsYield
Stage #1: 2,3,4-tri-O-acetyl-α-L-arabinopyranosyl-(1->4)-[2,3,4-tri-O-acetyl-α-L-arabinopyranosyl-(1->6)]-2,3-di-O-acetyl-β-D-glucopyranosyl trichloroacetimidate; sarsasapogenin With trimethylsilyl trifluoromethanesulfonate In dichloromethane at 0℃; for 0.666667h; Inert atmosphere;
Stage #2: With water; sodium hydroxide In methanol at 20℃; for 3h; pH=10;
93%
1-(tert-butoxycarbonyl)-L-proline
15761-39-4

1-(tert-butoxycarbonyl)-L-proline

sarsasapogenin
126-19-2

sarsasapogenin

C37H59NO6

C37H59NO6

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 12h;92.2%
2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl-(1->4)-[2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl-(1->6)]-2,3-di-O-acetyl-β-D-glucopyranosyl trichloroacetimidate
1344089-23-1

2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl-(1->4)-[2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl-(1->6)]-2,3-di-O-acetyl-β-D-glucopyranosyl trichloroacetimidate

sarsasapogenin
126-19-2

sarsasapogenin

sarsasapogenyl β-D-glucopyranosyl-(1->4)-[β-D-glucopyranosyl-(1->6)]-β-D-glucopyranoside
1344089-16-2

sarsasapogenyl β-D-glucopyranosyl-(1->4)-[β-D-glucopyranosyl-(1->6)]-β-D-glucopyranoside

Conditions
ConditionsYield
Stage #1: 2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl-(1->4)-[2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl-(1->6)]-2,3-di-O-acetyl-β-D-glucopyranosyl trichloroacetimidate; sarsasapogenin With trimethylsilyl trifluoromethanesulfonate In dichloromethane at 0℃; for 0.666667h; Inert atmosphere;
Stage #2: With water; sodium hydroxide In methanol at 20℃; for 3h; pH=10;
90%
N-tert-butoxycarbonyl-L-phenylalanine
13734-34-4

N-tert-butoxycarbonyl-L-phenylalanine

sarsasapogenin
126-19-2

sarsasapogenin

C41H61NO6

C41H61NO6

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 12h;89.5%
2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl-(1->4)-[2,3,4-tri-O-acetyl-α-L-arabinopyranosyl-(1->6)]-2,3-di-O-acetyl-β-D-glucopyranosyl trichloroacetimidate
1344089-21-9

2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl-(1->4)-[2,3,4-tri-O-acetyl-α-L-arabinopyranosyl-(1->6)]-2,3-di-O-acetyl-β-D-glucopyranosyl trichloroacetimidate

sarsasapogenin
126-19-2

sarsasapogenin

sarsasapogenyl β-D-glucopyranosyl-(1->4)-[α-L-arabinopyranosyl-(1->6)]-β-D-glucopyranoside

sarsasapogenyl β-D-glucopyranosyl-(1->4)-[α-L-arabinopyranosyl-(1->6)]-β-D-glucopyranoside

Conditions
ConditionsYield
Stage #1: 2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl-(1->4)-[2,3,4-tri-O-acetyl-α-L-arabinopyranosyl-(1->6)]-2,3-di-O-acetyl-β-D-glucopyranosyl trichloroacetimidate; sarsasapogenin With trimethylsilyl trifluoromethanesulfonate In dichloromethane at 0℃; for 0.666667h; Inert atmosphere;
Stage #2: With water; sodium hydroxide In methanool at 20℃; for 3h; pH=10;
89%
t-Boc-L-valine
13734-41-3

t-Boc-L-valine

sarsasapogenin
126-19-2

sarsasapogenin

C37H61NO6

C37H61NO6

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 12h;88.2%
L-N-Boc-Ala
15761-38-3

L-N-Boc-Ala

sarsasapogenin
126-19-2

sarsasapogenin

C35H57NO6

C35H57NO6

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 12h;86.8%
benzyl bromide
100-39-0

benzyl bromide

sarsasapogenin
126-19-2

sarsasapogenin

(25S)-3β-benzyloxy-5β-spirostan

(25S)-3β-benzyloxy-5β-spirostan

Conditions
ConditionsYield
Stage #1: sarsasapogenin With sodium hydride In N,N-dimethyl-formamide at -5℃; for 0.5h;
Stage #2: benzyl bromide In N,N-dimethyl-formamide at 80℃; for 16h;
80.2%
Stage #1: sarsasapogenin With sodium hydride In N,N-dimethyl-formamide; mineral oil at -5℃; for 0.5h;
Stage #2: benzyl bromide In N,N-dimethyl-formamide; mineral oil at 80℃; for 24h;
78.5%
Stage #1: sarsasapogenin With sodium hydride In N,N-dimethyl-formamide; mineral oil at -5℃; for 0.5h;
Stage #2: benzyl bromide In N,N-dimethyl-formamide at 80℃; for 24h;
78.5%
With sodium hydride In N,N-dimethyl-formamide at 20 - 40℃;75%
sarsasapogenin
126-19-2

sarsasapogenin

(25S)-3α-bromo-5β-spirostan

(25S)-3α-bromo-5β-spirostan

Conditions
ConditionsYield
With N-Bromosuccinimide; 2,2'-azobis(isobutyronitrile); triphenylphosphine In dichloromethane at 30℃;78%
p-Methoxybenzyl bromide
2746-25-0

p-Methoxybenzyl bromide

sarsasapogenin
126-19-2

sarsasapogenin

(25S)-3β-(4'-methoxybenzyloxy)-5β-spirostan

(25S)-3β-(4'-methoxybenzyloxy)-5β-spirostan

Conditions
ConditionsYield
Stage #1: sarsasapogenin With sodium hydride In N,N-dimethyl-formamide; mineral oil at -5℃; for 0.5h;
Stage #2: p-Methoxybenzyl bromide In N,N-dimethyl-formamide; mineral oil at 80℃; for 24h;
76%
N-tert-butoxycarbonyl-L-leucine
13139-15-6

N-tert-butoxycarbonyl-L-leucine

sarsasapogenin
126-19-2

sarsasapogenin

C38H63NO6

C38H63NO6

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 12h;74.8%
4-Fluorobenzyl bromide
459-46-1

4-Fluorobenzyl bromide

sarsasapogenin
126-19-2

sarsasapogenin

(25S)-3β-(4'-fluorobenzyloxy)-5β-spirostan

(25S)-3β-(4'-fluorobenzyloxy)-5β-spirostan

Conditions
ConditionsYield
Stage #1: sarsasapogenin With sodium hydride In N,N-dimethyl-formamide; mineral oil at -5℃; for 0.5h;
Stage #2: 4-Fluorobenzyl bromide In N,N-dimethyl-formamide; mineral oil at 80℃; for 24h;
71%
sarsasapogenin
126-19-2

sarsasapogenin

3,6-di-O-benzoylated-isopropyl-β-D-1-thiogalactopyranoside
615570-19-9

3,6-di-O-benzoylated-isopropyl-β-D-1-thiogalactopyranoside

sarsasapogenin 3,6-di-O-benzoyl-β-D-glucopyranose
1186633-13-5

sarsasapogenin 3,6-di-O-benzoyl-β-D-glucopyranose

Conditions
ConditionsYield
With N-iodo-succinimide; trimethylsilyl trifluoromethanesulfonate In dichloromethane at -42℃; for 0.833333h; Under N2 atmosphere;67%
With N-iodo-succinimide; triisopropylsilyl trifluoromethanesulfonate In dichloromethane at -42℃; for 1h; Inert atmosphere;49%
1-Brom-2-trichloracetyl-3,4,6-triacetyl-α-D-glucose
54612-87-2

1-Brom-2-trichloracetyl-3,4,6-triacetyl-α-D-glucose

sarsasapogenin
126-19-2

sarsasapogenin

A

C41H59Cl3O12

C41H59Cl3O12

B

C41H59Cl3O12

C41H59Cl3O12

Conditions
ConditionsYield
With Dierite; silver trifluoromethanesulfonate; tetramethylurea In dichloromethane for 1.5h; Ambient temperature;A 66.9%
B 19.1%
With Dierite; silver trifluoromethanesulfonate; tetramethylurea In dichloromethane for 6h; Ambient temperature;A 66.9%
B 19.1%
acetic anhydride
108-24-7

acetic anhydride

sarsasapogenin
126-19-2

sarsasapogenin

(25S)-5β-furost-20(22)-ene-3β,26-diyl diacetate
838087-02-8

(25S)-5β-furost-20(22)-ene-3β,26-diyl diacetate

Conditions
ConditionsYield
at 200℃; for 12h; Ring cleavage; acetylation;63.2%
Trichloro-acetic acid (2R,3R,4S,5S,6R)-4,5-diacetoxy-6-acetoxymethyl-2-bromo-tetrahydro-pyran-3-yl ester
54612-86-1

Trichloro-acetic acid (2R,3R,4S,5S,6R)-4,5-diacetoxy-6-acetoxymethyl-2-bromo-tetrahydro-pyran-3-yl ester

sarsasapogenin
126-19-2

sarsasapogenin

A

C41H59Cl3O12

C41H59Cl3O12

B

C41H59Cl3O12

C41H59Cl3O12

Conditions
ConditionsYield
With Dierite; silver trifluoromethanesulfonate; tetramethylurea In dichloromethane for 5h; Ambient temperature;A 62.1%
B 20.8%
sarsasapogenin
126-19-2

sarsasapogenin

(25S)-neospirost-4-en-3-one
56144-09-3

(25S)-neospirost-4-en-3-one

Conditions
ConditionsYield
With Mycobacteriu; sp. (NRRL B-3805) In N,N-dimethyl-formamide at 26 - 28℃; for 120h;62%
acetic anhydride
108-24-7

acetic anhydride

acetic acid
64-19-7

acetic acid

sarsasapogenin
126-19-2

sarsasapogenin

3β-acetoxy-5β-pregn-16-en-20-one
2601-07-2

3β-acetoxy-5β-pregn-16-en-20-one

Conditions
ConditionsYield
Stage #1: acetic anhydride; sarsasapogenin With pyridine; ammonium chloride at 150℃;
Stage #2: acetic acid With chromium(VI) oxide In water; 1,2-dichloro-ethane at 20 - 150℃;
58%

126-19-2Related news

Timosaponin AIII and its metabolite Sarsasapogenin (cas 126-19-2) ameliorate colitis in mice by inhibiting NF-κB and MAPK activation and restoring Th17/Treg cell balance10/01/2019

The rhizome of Anemarrhena asphodeloides (AA, family Liliaceae), which contains furostanol and spirostanol saponins, is a typical herbal medicine that improves learning and memory in rats and inhibits inflammation. In a preliminary study, timosaponin AIII, one of AA main constituents, was metabo...detailed

Synthesis and biological evaluation of novel Sarsasapogenin (cas 126-19-2) derivatives as potential anti-tumor agents09/27/2019

Based on the fact that timosaponin A-III (TA-III) exhibits potent cytotoxic effects and has been considered as a potential anti-tumor agent, a range of novel sarsasapogenin derivatives 1, 2a–2g, 3, 4, 5, 6a–6g have been synthesized by a simple and facile synthetic route. The in vitro cytotoxic...detailed

Quantitative determination of Sarsasapogenin (cas 126-19-2) in rat plasma using liquid chromatography-tandem mass spectrometry09/26/2019

Sarsasapogenin, a natural compound from Chinese medical herb Anemarrhena asphodeloides Bge., has recently received a great deal of attention due to its various bioactivities. In this study, an easy and applicable liquid chromatography tandem mass spectrometry method for the quantification of sar...detailed

Synthesis and SAR study of novel Sarsasapogenin (cas 126-19-2) derivatives as potent neuroprotective agents and NO production inhibitors09/10/2019

Sarsasapogenin, isolated from rhizomes of Anemarrhena asphodeloides, was found to be able to enhance memory. On the basis of the structure of Sarsasapogenin, a series of derivatives were synthesized and evaluated for their neuroprotective activity in PC12 cells and NO production inhibitory activ...detailed

Research paperSynthesis of new Sarsasapogenin (cas 126-19-2) derivatives with cytotoxicity and apoptosis-inducing activities in human breast cancer MCF-7 cells09/09/2019

Based on the fact that Timosaponin A-III, a saponin isolated from the rhizome of Anemarrhena asphodeloides, is a promising bioactive lead compound in the treatment of cancer, structural modification at the C3 and C26 positions of sarsasapogenin has always been the focus of our structure-activity...detailed

126-19-2Relevant articles and documents

Steroidal saponins from Asparagus racemosus

Sharma, Upendra,Saini, Rikki,Bobita,Kumar, Neeraj,Singh, Bikram

, p. 890 - 893 (2009)

Two new steroidal saponins, shatavaroside A (1) and shatavaroside B (2) together with a known saponin, filiasparoside C, were isolated from the roots of Asparagus racemosus. Filiasparoside C was first time isolated from this plant. Their structures were e

SPIROSTANOL GLYCOSIDE FROM FRUITS OF ASPARAGUS OFFICINALIS

Pant, G.,Panwar, M. S.,Negi, D. S.,Rawat, M. S. M.,Morris, G. A.

, p. 3324 - 3325 (1988)

A spirostanol glycoside was isolated, together with some known compounds, from the methanolic extract of the fruits of Asparagus officinalis and characterized by chemical and spectral methods including 13C NMR-DEPT and 2D-hetcor NMR spectra.The spirostanol glycoside caused 100percent immobilization of human spermatozoa at 1.5percent level.Key Word Index - Asparagus officinalis; Liliaceae; spirostanol glycoside; 13C NMR-DEPT mode; 2D-heteronuclear shift correlation NMR spectrum; spermicidal potential.

Filiasparosides A-D, cytotoxic steroidal saponins from the roots of Asparagus filicinus

Zhou, Li-Bo,Chen, Tzu-Hsuan,Bastow, Kenneth F.,Shibano, Makio,Lee, Kuo-Hsiung,Chen, Dao-Feng

, p. 1263 - 1267 (2007)

Four new steroidal saponins, filiasparosides A-D (1-4), together with known aspafiliosides A (5) and B (6) were isolated from the roots of Asparagus filicinus. The structures of these new compounds were elucidated by detailed spectroscopic study and chemical analysis. Compounds 1-6 were cytotoxic against human lung carcinoma (A549) and breast adenocarcinoma (MCF-7) tumor cell lines with EC50 values of 2.3-16.8 μg/mL. Compound 3 showed the most potent cytotoxicity, with EC50 values of 2.3 and 3.0 μg/mL toward A549 and MCF-7 cell lines, respectively.

-

Kenney,Wall

, p. 468 (1957)

-

-

Marker,Rohrmann

, p. 900 (1940)

-

Concise large-scale synthesis of tomatidine, a potent antibiotic natural product

Boudreault, Pierre-Luc,Normandin, Chad

, (2021/10/12)

Tomatidine has recently generated a lot of interest amongst the pharmacology, medicine, and biology fields of study, especially for its newfound activity as an antibiotic agent capable of targeting multiple strains of bacteria. In the light of its low natural abundance and high cost, an efficient and scalable multi-gram synthesis of tomatidine has been developed. This synthesis uses a Suzuki–Miyaura-type coupling reaction as a key step to graft an enantiopure F-ring side chain to the steroidal scaffold of the natural product, which was accessible from low-cost and commercially available diosgenin. A Lewis acid-mediated spiroketal opening followed by an azide substitution and reduction sequence is employed to generate the spiroaminoketal motif of the natural product. Overall, this synthesis produced 5.2 g in a single pass in 15 total steps and 15.2% yield using a methodology that is atom economical, scalable, and requires no flash chromatography purifications.

Gram-Scale Synthesis of Tomatidine, a Steroid Alkaloid with Antibiotic Properties Against Persistent Forms of Staphylococcus aureus

Normandin, Chad,Malouin, Fran?ois,Marsault, Eric

, p. 2693 - 2698 (2020/05/04)

We herein describe the first diastereoselective synthesis of the Solanum alkaloid tomatidine 1. The synthesis has been accomplished in 11 steps and 24.9 % overall yield (longest linear sequence). This methodology, which involves a convergent synthon insertion followed by a sequence of ring opening/nitrogen substitution/ring closing, allowed the generation of 1 on > 2 g scale. The synthetic challenge with the diastereoselective generation of the unusual spiroaminoketal moiety was solved through a combined azide reduction/addition sequence. The first diastereoselective synthesis of the phytosteroid yamogenin is also reported. Tomatidine has shown promising antibiotic properties against persistent forms of Staphylococcus aureus (S. aureus) and methicillin-resistant S. aureus (MRSA). In particular, it possesses the unique ability to kill persistent forms of S. aureus and MRSA while simultaneously potentiating the antibiotic efficacy of aminoglycoside antibiotics against wild type strains of the bacteria.

New transformation pathway and cytotoxic derivatives from the acid hydrolysis of timosaponin B III

Zhao, Yun-Fang,Zhang, Yu-Wei,Wang, Yinru,Morris-Natschke, Susan L.,Liu, Wei,Shang, Ting-Ting,Yin, Hong,Lee, Kuo-Hsiung,Huang, Xue-Feng

, p. 2755 - 2761 (2018/11/30)

Timosaponin B III is a major bioactive steroidal saponin isolated from Anemarrhena asphodeloides Bge. To potentially discover derivatives with better biological activity, timosaponin B III was structurally modified via acid hydrolysis to yield one new (2, timopregnane A I) C21 steroidal glycoside and seven known compounds. Their structures were elucidated on the basis of NMR spectroscopy and mass spectrometry. All eight compounds were evaluated for cytotoxic activity against MCF7, SW480, HepG2, and SGC7901 cell lines in vitro. As a result, compounds 6 and 7 showed significant activity (IC50 2.94–12.2 μM) against all tested cell lines. Structure–activity relationships of these compounds were investigated and the preliminary conclusions were provided. Moreover, a new transformation pathway was discovered in the acid hydrolysis of timosaponin B III for the first time.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 126-19-2